MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹1,727 Cr | ₹1,473 Cr | ₹1,334 Cr | ₹845 Cr | ₹604 Cr |
What is the latest Net Current Assets ratio of MARKSANS PHARMA ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹1,727 Cr |
Mar2024 | ₹1,473 Cr |
Mar2023 | ₹1,334 Cr |
Mar2022 | ₹845 Cr |
Mar2021 | ₹604 Cr |
How is Net Current Assets of MARKSANS PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹1,727 Cr | 17.26 | |
Mar2024 | ₹1,473 Cr | 10.37 | |
Mar2023 | ₹1,334 Cr | 57.91 | |
Mar2022 | ₹845 Cr | 39.93 | |
Mar2021 | ₹604 Cr | - |
Compare Net Current Assets of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,752.0 Cr | -1.2% | -24.9% | -28.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,388.0 Cr | -2.2% | -8.3% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,513.0 Cr | -1.1% | -7.3% | 21.6% | Stock Analytics | |
CIPLA | ₹126,733.0 Cr | -0.7% | 1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,292.0 Cr | -0.5% | -4.2% | 4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,935.0 Cr | -0.5% | -1.1% | -7.7% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -1.2% |
-24.9% |
-28.2% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses